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Abstract
Glutamate toxicity on PC12 cells is mediated by oxidative stress as a consequence of the inhibition of a cystine uptake system
with depletion of GSH. In this study we report that glutamate decreases PC12 cell viability, inhibiting the reduction of
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT). This decrease was prevented by the antioxidants vitamin E,
idebenone and L-deprenyl, which were also shown to be effective in reducing the accumulation of reactive oxygen species (ROS)
in cells exposed to glutamate, decreasing the fluorescence of 2%,7%-dichlorofluorescein (DCF). Incubation of PC12 cells with high
glutamate concentrations induced mitochondrial dysfunction, leading to the loss of mitochondrial transmembrane potential,
evaluated as a decrease in rhodamine 123 (Rh123) retention by mitochondria, and to the decrease of intracellular ATP levels. The
mitochondrial dysfunction, induced by glutamate, can be involved in the observed increase of [Ca2]i. The elevation of [Ca
2]i
occurred after GSH depletion, suggesting that oxidative stress is involved in the disturbances of intracellular calcium homeostasis.
In conclusion, our data indicate that glutamate, at concentrations which block cystine uptake in PC12 cells leading to GSH
depletion and inducing oxidative stress, increases ROS accumulation and decreases cell survival by a mechanism involving
mitochondrial dysfunction and impairment of Ca2 homeostasis. © 2000 Elsevier Science Ireland Ltd and the Japan Neuro-
science Society. All rights reserved.
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1. Introduction
Oxidative stress is thought to be related to various
neurodegenerative conditions and disorders including
ischemia-reperfusion, traumatic injury, Parkinson’s dis-
ease (PD) and Alzheimer’s disease (AD) (Kehrer, 1993;
Jenner, 1994; Bolan˜os et al., 1997). The amino acid
glutamate may induce oxidative stress in neurons and
has been implicated in various neurodegenerative dis-
eases (Coyle and Puttfarcken, 1993; Lees, 1993; Blan-
dini et al., 1996; Obrenovitch and Urenjak, 1997).
Glutamate may be directly toxic to cultured neuronal
cells via two different processes, both of which result in
the production of free radicals. The classical pathway,
known as excitotoxicity, occurs through the activation
of NMDA and non-NMDA glutamatergic receptors
(Olney, 1969) and subsequent calcium influx into the
cell (Michaels and Rothman, 1990). The oxidative glu-
tamate toxicity pathway is a transporter-mediated type
of cell death (Murphy et al., 1989) that requires the
cellular expression of the cystine:glutamate antiporter
system (Bannai, 1986), that has recently been described
in primary neuronal cultures (Bannai, 1986; Murphy et
al., 1989, 1990; Oka et al., 1993; Davis and Maher,
1994), in neuronal cell lines (Kato et al., 1984, 1992;
Murphy et al., 1989; Miyamoto et al., 1989; Davis and
Maher, 1994) and in tissue slices (Schubert et al., 1992).
The competition by glutamate for the cystine:glutamate
Abbre6iations: dbcAMP, dibutyryl cyclic AMP; DCF, 2%,7%-dichlor-
ofluorescein; DCFH2, 2%7%-dichlorofluorescin; DCFH2DA, 2%,7%-
dichlorofluorescin diacetate; Dcmit, mitochondrial transmembrane
potential; Fura-2, 1-[2-(5-carboxyoxazol-2-yl)-6-aminobenzofuran-5-
oxy]-2-2(2%-amino-5%-methyl-phenoxy)-ethane-N,N,N %,N %-tetracetic
acid; GSH, reduced form of glutathione; LDH, lactate dehydroge-
nase; NGF, nerve growth factor; NMDA, N-methyl-D-aspartate;
MTT, 3-(4,5-dimethylthiazol-2-yl)2,5-diphenyltetrazolium bromide;
Rh123, rhodamine 123; ROS, reactive oxygen species.
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antiporter induces an imbalance in the homeostasis of
cystine, the precursor of glutathione (GSH). Therefore,
the inhibition of cystine uptake by the constant and high
exposure to glutamate is supposed to give rise to an
inability to maintain intracellular GSH levels, leading to
a reduced ability to protect against oxidative injury of
the cell and, ultimately, cell death. The accumulation of
an excess of free radicals seems to be responsible for the
toxicity, because this second pathway can be blocked by
antioxidants (Miyamoto et al., 1989; Davis and Maher,
1994).
Recently, we have demonstrated, in agreement with
other authors (Vornov and Coyle, 1991; Froissard and
Duval, 1994), that exposure of PC12 cells to high doses
of glutamate decreases its survival (Pereira and Oliveira,
1997). Furthermore, we have reported that glutamate
toxicity is prevented by several antioxidants, suggesting
that the mechanism of cell damage induced by glutamate
is mediated by the increased generation of free radicals.
This mechanism involves the inhibition, by glutamate, of
a plasma membrane cystine uptake system and the
depletion of GSH levels, resulting in cell damage by its
inability to remove free radicals. GSH has been demon-
strated to detoxify hydroperoxides including the H2O2
formed during the oxidative metabolism of dopamine
(Murphy et al., 1990). The results of Maher and Davis
(1996), demonstrating a role for monoamines in gluta-
mate toxicity, may provide an explanation for glutamate
toxicity on a rat pheochromocytoma-derived PC12 cell
line, which consists of a homogenous population of
dopamine containing cells that have been demonstrated
to synthesize, store and release dopamine in a similar
manner to neurons (Greene and Rein, 1977).
The aim of the present study is to further define
oxidative glutamate toxicity, frequently used as an oxi-
dative stress paradigm (Behl et al., 1992, 1997; Caldero´n
et al., 1999), by determining the effect of prolonged
exposure of PC12 cells to high glutamate doses on the
mitochondrial function and calcium homeostasis. It is
clearly demonstrated that high glutamate concentrations
induce cell death through a mechanism involving an
increase in the levels of reactive oxygen species (ROS) as
a consequence of intracellular GSH depletion, which
leads, through mitochondrial dysfunction and perturba-
tion of intracellular Ca2 homeostasis, to cell death.
2. Materials and methods
2.1. Chemicals
L-Deprenyl was obtained from RBI (MA, USA).
Monosodium L-glutamate, dibutyryl cyclic AMP (db-
cAMP), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetra-
zolium bromide (MTT), and D-a-tocopherol succin-
ate were purchased from Sigma (USA). The 1-[2-(5-
carboxyoxazol-2-yl)-6-aminobenzofuran-5-oxy]-2-(2%-
amino-5%-methyl-phenoxy)-ethane-N,N,N %,N %-tetracetic
acid, penta-acetoxymethyl ester (Fura-2:AM), 2%,7%-
dichlorofluorescin diacetate (DCFH2-DA), and Rh123
were purchased from Molecular Probes Inc. (Eugene,
OR). GSH-400 colorimetric kit was obtained from
Bioxytech (France). 45Ca2 was purchased from Amer-
sham International (Amersham Centre, UK). All other
reagents were of analytical grade. Idebenone was a
generous gift from Seber, Portugal.
2.2. Cell culture and analysis of glutamate toxicity
Stock cultures of PC12 cells (Greene and Tischler,
1976) were grown routinely in RPMI 1640 medium
supplemented with 10% heat-inactivated horse serum
and 5% heat-inactivated fetal calf serum, to which
penicillin (50 U:ml) and streptomycin (50 mg:ml) were
added, and maintained at 37°C in a humidified incuba-
tor containing 95% air and 5% CO2. For differentiation,
cells were plated on poly-L-lysine-coated (10 mg:ml)
24-well dishes (0.5 ml:well). Twenty-four hours after
seeding, cells were washed twice in RPMI 1640 medium
and differentiation was induced by adding 50 ng:ml of
nerve growth factor (NGF 2.5 S) plus 1 mM dibutyryl
cyclic AMP (dbcAMP). The medium was changed every
2 days and after 7 days in culture, in the presence of
NGF and dbcAMP, cells were used for toxicity studies.
Twenty-four hours after seeding, the medium was
renewed by fresh medium containing the desired gluta-
mate concentration. When antioxidants were tested,
cells were simultaneously incubated in the presence of
glutamate and 10 mM vitamin E (a-tocopherol-succi-
nate), 500 mM L-deprenyl or 1 mM idebenone. Vitamin
E and idebenone were previously preincubated for 24 h
before glutamate addition (and maintained during gluta-
mate exposure) in order to allow the incorporation of
these antioxidants in biological membranes. After the
desired incubation period, the culture medium and:or
the cells were analyzed for MTT reduction (Mosmann,
1983). In brief, MTT was dissolved in PBS at 5 mg:ml
and was 10-fold diluted in serum-free RPMI 1640
medium. After incubation of the cells with the com-
pounds to be tested, the medium was aspirated and
MTT (0.5 mg:ml) containing serum-free medium was
added. After an additional 3 h incubation at 37°C,
isopropanol:HCl was added to each well and the ab-
sorbance of solubilized MTT formazan products was
measured at 570 nm.
2.3. Measurement of intracellular ROS formation
Formation of intracellular peroxides was detected
with a fluorescent spectrophotometer using a non-
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fluorescent compound, 2%,7%-dichlorofluorescin di-
acetate (DCFH2-DA), which is de-esterified within cells
by endogenous esterases to the ionized free acid,
2%,7%-dichlorofluorescin (Bass et al., 1983). 2%,7%-
Dichlorofluorescin is capable of being oxidized to
fluorescent 2%,7%-dichlorofluorescein (DCF) by hydro-
peroxides. After exposure to glutamate, with or without
antioxidants, the cells were incubated in 2 ml of 140
mM NaCl, 5 mM KCl, 1 mM MgCl2, 5.6 mM glucose,
1.5 mM CaCl2 and 20 mM Hepes-Na, pH 7.4, and
allowed to take up 5 mM DCFH2-DA at 37°C for 20
min, in an atmosphere of 95% air and 5% CO2. After
loading with DCFH2-DA, cells were washed with the
same buffer and fluorescence was measured at 502 nm
excitation and 550 nm emission.
2.4. Analysis of mitochondrial membrane potential
The changes in mitochondrial membrane potential
(DCmit) were estimated using the fluorescent cationic
dye Rh123, which accumulates in mitochondria as a
direct function of the membrane potential and is re-
leased upon membrane depolarization (Palmeira et al.,
1996). After exposure to glutamate, the cells were incu-
bated for 10 min at 37°C with Rh123 (1 mM), in an
atmosphere of 95% air and 5% CO2. Cells were then
washed with 140 mM NaCl, 5 mM KCl, 1 mM MgCl2,
5.6 mM glucose, 1.5 mM CaCl2 and 20 mM Hepes-Na
(final pH 7.4) and transferred to a fluorometer cuvette.
The dye remaining trapped in the cells was determined
by fluorimetric analysis at excitation and emission
wavelengths of 490 and 515 nm, respectively, at 37°C.
Triton X-100 was added in order to disrupt the cells
and establish the maximum retention of Rh123.
2.5. Analysis of adenine nucleotides
After the incubation period, the medium was re-
moved and PC12 cells were extracted, in ice, with 0.3 M
perchloric acid. The cells were scraped from the wells
and centrifuged at 15 800g for 5 min. The pellets
were solubilized with 1 M NaOH and analyzed for total
protein content (Sedmak and Grossberg, 1977). The
supernatants were neutralized with 10 M KOH in 5 M
Tris and centrifuged. The resulting supernatants were
assayed for adenine nucleotides by separation in a
reverse-phase HPLC, as described by Stocchi et al.
(1985). The chromatographic apparatus used was a
Beckman System Gold, consisting of a 126 Binary
Pump Model and a 166 Variable UV detector, con-
trolled by a computer. The column used was a Lichro-
spher 100 RP-18 (5 mm) from Merck. An isocratic
elution with 100 mM KH2PO4 buffer, at pH 7.4, and
1% methanol was performed at a flow rate of 1.2
ml:min. The adenine nucleotides were detected at 254
nm, for 6 min.
2.6. Measurement of intracellular calcium
concentration, [Ca2]i, and determination of 45Ca2
uptake
The concentration of intracellular Ca2 was mea-
sured with Fura-2:AM, a calcium fluorescent ester
chelator and indicator (Di Virgilio et al., 1988). After
glutamate incubation, cells were harvested by gentle
scraping, washed and resuspended in a standard
medium containing 140 mM NaCl, 5 mM KCl, 1 mM
MgCl2, 5.6 mM glucose, 1.5 mM CaCl2 and 20 mM
Hepes-Na (final pH 7.4), which was used for loading
and for the subsequent fluorescence measurements (Liu
et al., 1991). Fura-2:AM (5 mM) was added to the cell
suspension, which was subsequently incubated for 30
min. The cells were then washed, resuspended in the
standard medium and transferred to thermostatically
controlled cuvettes equipped with a magnetic stirrer.
The fluorescence intensity of Fura-2 was quantified
with a fluorescence spectrophotometer, with a single
excitation wavelength set at 340 nm and an emission
wavelength monitored at 510 nm (Vrasenic and
Kno¨pfel, 1991). [Ca2]i was calculated from the fura-2
fluorescence intensity using the equation: [Ca2]i
KD(FFmin):(FmaxF). The maximal Fura-2 fluores-
cence intensity (Fmax) was determined by adding 5 mM
ionomycin and the minimal fluorescence (Fmin) was
determined by quenching Fura-2 fluorescence with 5
mM EGTA plus 20 mM Tris-base, pH 8.5 and 0.1%
Triton X-100 to lyse the cells.
45Ca2 uptake was determined as described by
Eimerl and Schramm (1993). After incubation with
glutamate, cells were washed twice with Na medium
(140 mM NaCl, 5 mM KCl, 5 mM MgCl2, 5 mM
KH2PO4, 20 mM Hepes-Na, 1.5 mM CaCl2, pH 7.4)
and then incubated in 2 ml Na medium containing 1.0
mM unlabeled CaCl2 and 1.5 mCi:ml 45Ca2 for 10 min
at 37°C. The incubation was stopped by rapidly wash-
ing the monolayers twice with ice-cold Na medium
(140 mM NaCl, 5 mM KCl, 5 mM MgCl2, 20 mM
Hepes-Na, 1.5 mM CaCl2, pH 7.4) supplemented with 1
mM LaCl3 and finally once with ice-cold Na medium
supplemented with LaCl3 and also with 1 mM EGTA,
followed by addition of 0.1 M NaOH. Aliquots of the
cell digests were used for liquid scintillation counting
and for protein determination (Sedmak and Grossberg,
1977).
2.7. Quantification of endogenous GSH le6els
Cellular levels of GSH were determined using a
GSH-400 colorimetric assay kit. PC12 cells were grown
for 24–48 h before being incubated with glutamate (0.5
or 10 mM) for different periods of time. The medium
was then discarded and the cells were washed twice in
PBS, resuspended in 400 ml of 5% (w:v) metaphospho-
C.F. Pereira, C.R. Oli6eira : Neuroscience Research 37 (2000) 227–236230
ric acid (MPA) and finally they were scraped and
centrifuged. The assay was performed on 200-ml
aliquots of centrifugation supernatants (3000g, 4°C,
10 min), according to the manufacturer’s instructions.
The pellets were resuspended in 200 ml of lysis buffer
for subsequent protein determination by the Biuret
method (Layne, 1957).
2.8. Data analysis
Throughout the text, data are expressed as means
9S.E.M. of triplicate determinations, from at least
three independent experiments. Statistical signific-
ance analysis was determined using the two-tailed un-
paired Student’s t-test or analysis of variance
(ANOVA) for multiple comparisons, followed by the
Turkey–Kramer posthoc test (PB0.05 was considered
significant).
3. Results
3.1. Antioxidants protect PC12 cells against
glutamate-induced toxicity
The dose-dependent glutamate toxicity was evaluated
by determining the percentage of MTT reduction upon
Fig. 2. Effect of the antioxidants vitamin E, idebenone and L-
deprenyl on glutamate-induced toxicity. Cells were plated and grown
for 24 h in culture medium; they were then switched to fresh medium
in the presence of 0.5 or 10 mM glutamate. Cells were preincubated
for 24 h with 10 mM vitamin E or 1 mM idebenone. Simultaneously
with glutamate incubation, the antioxidants (10 mM vitamin E, 1 mM
idebenone and 500 mM L-deprenyl) were added and the percentage of
MTT reduction was assessed 24 h after glutamate addition. The
results are the means9S.E.M. of triplicate determinations in 3–18
distinct experiments. **PB0.01, ***PB0.001, significantly different
compared to control conditions, in the absence of glutamate, at the
same incubation period. PB0.05,  PB0.01,   PB0.001,
significantly different compared to glutamate-treated control, in the
absence of antioxidants.
Fig. 1. Dose–response curve of the effect of glutamate on the
viability of undifferentiated and differentiated PC12 cells. Cells,
plated and grown for 24 h in culture medium, or cells differentiated
in the presence of NGF plus dbcAMP for 7 days, were switched to
fresh medium in the absence or in the presence of increasing gluta-
mate concentrations (0.1–10 mM). The reduction of the tetrazolium
salt MTT were assessed 24 h later. The results, are the means9
S.E.M. of triplicate determinations in 5–24 distinct experiments.
***PB0.001, significantly different compared to control conditions,
in the absence of glutamate.
incubation of differentiated and non-differentiated
PC12 cells for 24 h with increasing glutamate concen-
trations in the range 0.1–10 mM. As shown in Fig. 1,
increasing glutamate concentrations induced a decrease
in cellular viability in a dose-dependent manner, both in
untreated and NGF plus dbcAMP-treated PC12 cells,
with a significant decrease of MTT reduction ability
measured after incubation of the cells with 0.5 mM
glutamate.
The protective effect of several antioxidants with
different mechanisms of action, namely vitamin E,
idebenone and L-deprenyl, on the toxic effects of gluta-
mate induced by the incubation with this amino acid
for 24 h was tested (Fig. 2). Idebenone completely
protected PC12 cells from cell damage induced by
incubation with 0.5 mM or 10 mM glutamate. Also,
L-deprenyl induced a great protection against 0.5 mM
glutamate-induced toxicity, while the protection exerted
against 10 mM glutamate was only partial, although it
was significant (an increase of approximately 15% in
cellular viability was observed). Vitamin E also pro-
tected PC12 cells against the glutamate-induced de-
crease in cellular viability (MTT reduction in cells
incubated with 0.5 mM glutamate in the presence of
vitamin E was similar to that in control cells while in
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cells exposed to 10 mM glutamate, this antioxidant
increased the reduction of MTT by about 25%).
3.2. High glutamate concentrations induce the
accumulation of ROS
To clarify the involvement of oxygen radicals in
glutamate-induced toxicity in PC12 cells we have mea-
sured the accumulation of ROS after glutamate expo-
sure, utilizing a converting reaction of DCFH2-DA to
DCF (Fig. 3). ROS accumulation, determined by the
measurement of DCF fluorescence (expressed in arbi-
trary units) was increased 1.4- and 2.3-fold after treat-
ment with 0.5 and 10 mM glutamate, respectively, in
comparison with untreated controls. In the presence of
antioxidants, the increased ROS accumulation induced
by glutamate was clearly suppressed (Fig. 3). The DCF
fluorescence determined after incubation of cells with
0.5 or 10 mM glutamate, in the presence of vitamin E,
idebenone and L-deprenyl, was similar to that deter-
mined in control cells, incubated in the absence of
glutamate.
3.3. Glutamate leads to the impairment of
mitochondrial function in PC12 cells
The decrease of the mitochondrial membrane poten-
tial induced by glutamate was evaluated by determining
the cellular retention of Rh123, which is known to be
selectively taken up by mitochondria and to reflect the
maintenance of the mitochondrial potential. As shown
in Table 1, treatment of PC12 cells with cytotoxic doses
of glutamate (0.5 and 10 mM), leads to a significant
drop of Rh123 retention.
The determination of the intracellular ATP, ADP
and AMP levels of PC12 cells, incubated for 24 h in the
presence or in the absence of high glutamate concentra-
tions (0.5 and 10 mM), was also used to demonstrate
that the mitochondrial function is severely impaired by
glutamate. It was observed that glutamate, at the con-
centrations tested (0.5 and 10 mM), was able to reduce
significantly the ATP levels of the cells, which decreased
to approximately 72 and 53% of control values, respec-
tively (Table 2).
3.4. The intracellular Ca2 homeostasis in PC12 cells
is perturbed by glutamate-induced oxidati6e stress
Basal levels of [Ca2]i, measured in Fura-2-loaded
cells, were increased in a time-dependent manner in
cells treated with 0.5 and 10 mM glutamate. A signifi-
cant increase in the intracellular Ca2 concentration, in
comparison with controls, was observed after exposure
of the cells for 12 h to glutamate (Fig. 4A).
The uptake of 45Ca2, was not significantly affected
by treatment of PC12 cells with toxic concentrations of
glutamate (Table 3).
3.5. Glutamate decreases GSH le6els
The time-course analysis of GSH depletion shows
that the endogenous levels of this cellular thiol are
Fig. 3. Glutamate-stimulated intracellular accumulation of ROS in
PC12 cells. Formation of ROS after 24 h of glutamate exposure was
detected using 2%,7%-dichlorofluorescin diacetate oxidation and fluores-
cence. PC12 cells were cultured for 24 h in standard RPMI 1640
medium with 0.5 or 10 mM glutamate or with glutamate (0.5 or 10
mM) plus either vitamin E (10 mM), idebenone (1 mM) and L-
deprenyl (500 mM). Vitamin E and idebenone were added for preincu-
bation, in the absence of glutamate, during 24 h. The rate of DCF
formation was then evaluated as described in Section 2. The results,
expressed as arbitrary units of DCF fluorescence, are the means9
S.E.M. of triplicate determinations in 3–11 distinct experiments.
*PB0.05, ***PB0.001, significantly different compared to control
conditions, in the absence of glutamate. PB0.05,  PB0.01,
  PB0.001, significantly different compared to glutamate-treated
control, in the absence of antioxidants.
Table 1
Effect of glutamate on mitochondrial membrane potential (Rh123
retention)a




a Mitochondrial membrane potential was evaluated by the capacity
of the cells to take up the fluorescent cationic dye Rh23, following
cell incubation in the absence or presence of glutamate during 24 h.
Results are expressed as the percentage of Rh123 fluorescence re-
maining trapped by the cells, relative to control conditions, and are
means9S.E.M. of 3–7 different experiments.
* PB0.05 significantly different compared to control conditions, in
the absence of glutamate.
** PB0.01, significantly different compared to control conditions,
in the absence of glutamate.
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Table 2
Effect of glutamate on the intracellular levels of adenine nucleotidesa
ADP (nmol:mg protein)[Glutamate] (mM) AMP (nmol:mg protein)ATP (nmol:mg protein)
1.25490.1430 1.47590.16816.00591.404
0.5 11.50791.205* 1.42390.03* 1.16090.112
1.76190.245* 1.00290.11810 8.41390.794**
a After incubation during 24 h, in the presence or absence of glutamate (0.5 or 10 mM), PC12 cells were extracted with perchloric acid and the
resulting supernatants were assayed for adenine nucleotides by separation in a reverse-phase HPLC, as described in Section 2.
* PB0.05, significantly different compared to control conditions, in the absence of glutamate, in the same incubation period.
** PB0.01, significantly different compared to control conditions, in the absence of glutamate, in the same incubation period.
significantly decreased after a 6-h incubation period in
the presence of 0.5 or 10 mM glutamate (Fig. 4B). The
depletion of GSH was shown to occur earlier than the
observed increase in the intracellular Ca2 levels (Fig.
4A).
4. Discussion
We have previously demonstrated that: glutamate is
toxic to PC12 cells in a dose- and time-dependent
manner, as determined by the leakage of LDH; gluta-
mate-induced cell death results from the inhibition of
cystine uptake and depletion of intracellular GSH lev-
els; oxidative stress seems to be responsible for the
toxicity, since several antioxidants were shown to be
protective against glutamate-induced LDH leakage
(Pereira and Oliveira, 1997). Furthermore, we have
shown that glutamate toxicity is independent of the
activation of NMDA or non-NMDA glutamate recep-
tors (Pereira et al., 1998). The purpose of this work was
to further define cytotoxic oxidative stress on PC12
cells.
The results we have obtained demonstrate that gluta-
mate decreases the viability of PC12 cells, as deter-
mined by the MTT reduction assay (Fig. 1) and that
several antioxidants protect cells against glutamate-in-
duced inhibition of MTT reduction (Fig. 2), further
supporting the hypothesis that oxidative stress is in-
volved in glutamate toxicity.
The peroxide-sensitive dye DCF, which has the ad-
vantage of providing insight into total cytosolic ROS
levels, was used to document that glutamate induced
the accumulation of ROS in PC12 cells. A significant
increase in hydroperoxides accumulation, evaluated as
an increased rate of DCF formation, could be seen 24
h after glutamate treatment, several antioxidants being
able to prevent this effect of glutamate (Fig. 3). The
protective actions of antioxidants are not mediated by
the recovery of cellular GSH levels, as demonstrated by
our previous finding that vitamin E, idebenone and
L-deprenyl did not affect the decreased GSH levels
produced by glutamate (Pereira and Oliveira, 1997).
However, these compounds inhibit glutamate-induced
Fig. 4. Time-course of increase of intracellular Ca2 levels (A) and
GSH depletion (B) induced by glutamate treatment. [Ca2]i and
GSH levels were measured, as described in Section 2, after incubation
with 0.5 or 10 mM glutamate for 30 min, 1, 3, 6, 12 or 24 h. Results,
expressed as the percentage of increase of [Ca2]i or decrease of GSH
levels relative to controls, correspond to the means9S.E.M. of
triplicate determinations in three distinct experiments. **PB0.01;
***PB0.001, significantly different compared to control conditions,
in the absence of glutamate.
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Table 3
Effect of glutamate on the 45Ca2 uptake by PC12 cellsa




a Uptake of 45Ca2 by PC12 cells after exposure for 24 h to 0.5 or
10 mM glutamate was determined in the presence of 1 mM unlabeled
CaCl2 and 1.5 mCi:ml 45Ca2 for 10 min at 37°C, as described in
Section 2. Values are the means9S.E.M. of triplicate determinations
in six distinct experiments.
of mitochondria, probably due to lipid peroxidation,
do not allow the recovery of ATP levels by the gly-
colytic pathway.
The oxidative stress-induced drop in mitochondrial
membrane potential has been demonstrated to be as-
sociated with Ca2 ion leakage from these organelles
(Lo¨tscher et al., 1980; Nishida et al., 1989; Van de
Water et al., 1994), which could probably explain the
increase in intracellular Ca2 levels observed after glu-
tamate exposure (Fig. 4A). Under oxidative stress con-
ditions, Ca2 leakage is associated with the reuptake
of the ion by the electrogenic uniport system, and the
resulting Ca2 cycling causes energy dissipation with
the fall in membrane potential and a blocking of ATP
resynthesis (Richter, 1997). As mentioned above, a
significant reduction of the intracellular ATP levels
was observed in cells exposed to high glutamate con-
centrations (0.5 and 10 mM) during 24 h (Table 2).
The increased intracellular levels of free Ca2, ob-
served after treatment of PC12 cells with high doses of
glutamate (Fig. 4A), suggest a role for Ca2 in gluta-
mate-induced cell death. With decreased levels of
GSH, the ability of the cells to scavenge free radicals
formed by Ca2-dependent pathways, i.e. lipooxyge-
nases and phospholipases (Baba et al., 1986) may be
impaired. Consistent with this interpretation, the
lipooxygenase inhibitors and phospholipase A2 in-
hibitors reduce the cytotoxicity of glutamate in N18-
RE-105 cells, although they did not protect the
depletion of GSH levels (Murphy et al., 1989). The
observed protective effects of divalent metals against
low-cystine-type cell death and glutamate-induced cell
death (Murphy et al., 1988) suggest that intracellular
oxidants may be able to produce prolonged activation
of voltage-sensitive Ca2 channels. The activity of
voltage-dependent Ca2 channels and other Ca2 up-
take systems, known to be sensitive to oxidation
(Reeves et al., 1986; Roveri et al., 1992; Rohn et al.,
1993; Pereira et al., 1996), does not seem to be com-
promised under our experimental conditions because
the uptake of calcium was not significantly different in
control and glutamate-treated cells (Table 3). The in-
crease in intracellular Ca2 levels could result from
the impairment of plasma membrane extrusion mecha-
nisms, inhibition of sequestration by intracellular or-
ganelles or from the release of Ca2 from intracellular
stores. Previous studies of liver cells demonstrated that
prooxidants are able to impair mitochondrial function
leading to Ca2 release from mitochondria (Richter
and Schlegel, 1993). Therefore, the contribution of mi-
tochondrial dysfunction induced by glutamate on
PC12 cells, to the increased [Ca2]i cannot be ruled
out.
It has been reported that depletion of cellular GSH
is cytotoxic when followed by a decline in cellular
energy status (Redegeld et al., 1992). Depletion of
mitochondrial GSH, imported from the cytosol
stimulation of peroxide accumulation (Fig. 3), which
implies that the antioxidants directly protect the cells
from the glutamate-induced cytotoxicity through the
inhibition of peroxide formation or lipid peroxidation,
in spite of the depletion of GSH. Decreased levels of
GSH may lower the capacity of the cells to scavenge
H2O2, released during normal dopamine metabolism,
enhancing oxidative stress, disturbance of cellular
function, and eventually leading to cell death (Spina
and Cohen, 1989). The observed protection afforded
against glutamate-induced toxicity by L-deprenyl, an
inhibitor of the oxidative deamination of dopamine
(Gerlach et al., 1992), suggests a role for monoamines
in glutamate toxicity in this rat pheochromocytoma-
derived cell line.
The results here presented show that glutamate de-
creases the mitochondrial transmembrane potential, re-
sulting in the reduction of mitochondrial retention of
Rh123 (Table 1), which supports the hypothesis that
glutamate induces mitochondrial dysfunction in PC12
cells. The loss of the mitochondrial transmembrane
potential, induced by glutamate, may be caused, at
least in part, by an increase in peroxide accumulation.
Several groups have similarly noticed impairment in
the mitochondrial membrane potential under oxidative
stress conditions, caused by the increased generation
of oxygen free radicals (Carini et al., 1992; Sastre et
al., 1996; Vimard et al., 1996; Kruidering et al., 1997).
The determination of the intracellular ATP, ADP and
AMP levels of PC12 cells, incubated for 24 h in the
presence or in the absence of high glutamate concen-
trations, also supported the conclusion that the mito-
chondrial function is severely impaired by glutamate.
It was demonstrated that glutamate, at the concentra-
tions tested (0.5 and 10 mM), was able to reduce
significantly the ATP levels of the cells (Table 2). The
high activity of glycolysis to support ATP synthesis in
this cell line (Pereira et al., 1998) may be responsible
for the maintenance of ATP levels above a certain
threshold when the cells were incubated in the pres-
ence of 0.5 mM glutamate. In the presence of high
doses of glutamate (10 mM), the extensive alterations
C.F. Pereira, C.R. Oli6eira : Neuroscience Research 37 (2000) 227–236234
(Griffith and Meister, 1985), may result in impaired
mitochondrial function (Heales et al., 1995), since all
the complexes of the electron transport chain are re-
ported to be susceptible to damage by oxygen free
radicals, in vitro (Benzi and Moretti, 1995). The work
of Nishikawa et al. (1997) demonstrated that cytosolic
GSH rather than intramitochondrial GSH, might be
an important factor stabilizing the energy metabolism
of mitochondria. Bolan˜os et al. (1996) showed that
reduced GSH may be an important defense against the
damage to the neuronal mitochondrial respiratory
chain induced by sustained exposure to free radicals.
The depletion of GSH, induced by glutamate exposure
(Fig. 4B), might be involved in the impairment of
energy metabolism observed under our experimental
conditions, the decrease of the endogenous levels of
GSH preceding ROS accumulation and mitochondrial
dysfunction. Recently, we have shown that oxidative
stress conditions, which lead to GSH depletion, induce
impairment of mitochondrial function (Cardoso et al.,
1998, 1999). Furthermore, the depletion of GSH prior
to the increase of intracellular Ca2 levels, supports
the hypothesis that ROS contribute to the disturbance
of Ca2 homeostasis. Jurma et al. (1997) observed
that in PC12 cells depleted of GSH, the increased cell
loss appeared to be due to increased levels of ROS
and a subsequent rise of Ca2 levels. It should be
noted that neuronal injury, resulting from hydrogen
peroxide exposure, can be mimicked in PC12 cells by
treatment with the calcium ionophore ionomycin, sug-
gesting that ROS may indeed elicit their destructive
effects in PC12 cells via disruption of intracellular
calcium homeostasis (Hinshaw et al., 1993).
In conclusion, we have shown that oxidative gluta-
mate toxicity leads to mitochondrial dysfunction and
that it can probably be responsible for the leakage of
Ca2 ions from the mitochondria, increasing its intra-
cellular concentration. The impairment of mitochon-
drial function and perturbation of calcium homeostasis
can help to elucidate the mechanisms of glutamate-in-
duced oxidative stress and cell death in PC12 cells.
Furthermore, the data presented in this study suggest
that the decreased cell survival is due to apoptotic cell
death since it has been described that apoptosis is
characterized by depolarization of mitochondrial mem-
brane (Kroemer et al., 1997), generation of ROS and
increase of intracellular calcium levels (Kruman et al.,
1998), which have been observed upon exposure of
PC12 cells to glutamate.
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